Increased expression of aromatase in ADH and DCIS vs. normal breast tissues has been observed [41, 43], and a correlation was reported between aromatase overexpression and elevated in situ E2 concentrations in DCIS. This evidence concerns the gene CYP19A1 and ductal breast carcinoma in situ.